Identifying Which Adverse Events Associated With Dry Needling Should be Included For Informed Consent: A Modified e-Delphi Study
1 other identifier
observational
39
1 country
1
Brief Summary
Dry Needling is an intervention that continues to gain widespread interest as a treatment adjunct for various pathological conditions. With the increased use of dry needling in the clinic, there comes a need for additional research to investigate the adverse events associated with the use of dry needling. Informed Consent is a process that is legally required in many states prior to the performance of a treatment intervention like dry needling. It is important therefore to identify which of these adverse events should be included in an informed consent process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2022
CompletedFirst Submitted
Initial submission to the registry
March 19, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedJune 13, 2023
June 1, 2023
5 months
March 19, 2022
June 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Demographic Information Form
Contains questions about the characteristics of the participants
Baseline
Round 1 Questionnaire
Participants list known adverse events associated with dry needling
Baseline to 3 weeks
Round 2 Questionnaire
Participants identify which adverse events they agree should be included during informed consent.
3 weeks to 6 weeks
Round 3 Questionnaire
Participants will see the results from round 2 and further identify which adverse events should be included for informed consent.
6 weeks to 9 weeks
Study Arms (1)
Dry Needling Experts
Experts will be defined as adult individuals with a high level of knowledge within the area of patient safety and adverse events related to dry needling which will be confirmed using the following eligibility criteria: (1) Must have \>= 5 years of clinical practice performing dry needling and at least ONE of the following secondary criteria: 1. Certification in Dry Needling 2. Completion of a manual therapy fellowship that included dry needling training 3. \>= 1 total scholarly product (poster presentation, author of a peer-reviewed publication) involving the use of dry needling Eligible participants will be identified through existing professional networks and social media/internet-based searching. They will be recruited worldwide and be aged 18 or above, able to read and write in English, and willing to provide signed informed consent.
Interventions
This study involves the use of questionnaires across 3 rounds as follows: The objectives of round 1 are to collect participant demographic information and generate a list of adverse events. Round 1 will be open for 3 weeks with email reminders being provided at weeks 1 and 2. The objectives of round 2 will be to share a list of adverse events generated from round 1 (with the addition of adverse events identified in literature if not generated in round 1) and allow participants to rate from 1-4 how important each item is for inclusion on informed consent. As per round 1, the round 2 questionnaire will remain active for 3 weeks with email reminders sent at weeks 1 and 2. The objective of round 3 is to further gain consensus on adverse events from the results of round 2 where agreement was not reached. Round 3 remains active for 3 weeks with email reminders sent at weeks 1 and 2.
Eligibility Criteria
Physical Therapists who have \>= 7 years of experience performing dry needling and at least ONE of the following secondary criteria: 1. Certification in Dry Needling 2. Completion of a manual therapy fellowship that included dry needling training 3. \>= 1 total scholarly product (poster presentation, author of a peer-reviewed publication)
You may qualify if:
- Physical Therapists who:
- Have \>= 7 years of clinical practice performing dry needling and at least ONE of the following secondary criteria:
- Certification in Dry Needling
- Completion of a manual therapy fellowship that included dry needling training
- \>= 1 total scholarly product (poster presentation, author of a peer-reviewed publication)
You may not qualify if:
- Not a Physical Therapist
- Has less than 7 years experience in dry needling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Youngstown State University
Youngstown, Ohio, 44555, United States
Related Publications (1)
Funabashi M, Pohlman KA, Gorrell LM, Salsbury SA, Bergna A, Heneghan NR. Expert consensus on a standardised definition and severity classification for adverse events associated with spinal and peripheral joint manipulation and mobilisation: protocol for an international e-Delphi study. BMJ Open. 2021 Nov 11;11(11):e050219. doi: 10.1136/bmjopen-2021-050219.
PMID: 34764170BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
March 19, 2022
First Posted
March 29, 2022
Study Start
March 2, 2022
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
June 13, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share